Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARHGEF2 |
| Upstream (Parents) |
|---|
| (<<) AIFM1 → ARHGEF2 |
| (<<) BCL2A1 → ARHGEF2 |
| (<<) GOT2 → ARHGEF2 |
| (<<) IER2 → ARHGEF2 |
| (<<) PABPC3 → ARHGEF2 |
| (<<) PLAU → ARHGEF2 |
| (<<) PTPRE → ARHGEF2 |
| (<<) RHOA → ARHGEF2 |
| (<<) SULF1 → ARHGEF2 |
| (<<) TAGLN2 → ARHGEF2 |
| (<<) TSPAN3 → ARHGEF2 |
| (<<) VIM → ARHGEF2 |
| Downstream (Children) |
|---|
| ARHGEF2 → ACAT2 (>>) |
| ARHGEF2 → CORO1A (>>) |
| ARHGEF2 → CREB3L1 (>>) |
| ARHGEF2 → CRLF3 (>>) |
| ARHGEF2 → CTPS (>>) |
| ARHGEF2 → EBP (>>) |
| ARHGEF2 → EGFR (>>) |
| ARHGEF2 → FGF3 (>>) |
| ARHGEF2 → FGF7 (>>) |
| ARHGEF2 → FZD2 (>>) |
| ARHGEF2 → ITGB7 (>>) |
| ARHGEF2 → KLF2 (>>) |
| ARHGEF2 → MVK (>>) |
| ARHGEF2 → NFKB1 (>>) |
| ARHGEF2 → PDIA4 (>>) |
| ARHGEF2 → PIK3C2B (>>) |
| ARHGEF2 → PSAT1 (>>) |
| ARHGEF2 → RPS14 (>>) |
| ARHGEF2 → RRAS2 (>>) |
